NCT02295059 2026-04-03
Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention
City of Hope Medical Center
Phase NA Active not recruiting
Clinical Trials
12 trialsNCT06123286 2026-03-03
Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Recruiting
NCT01881048 2026-01-29
Window of Opportunity Study Targeting the Inflammatory Milieu
University of Colorado, Denver
Phase EARLY_PHASE1 Completed
NCT06111378 2023-11-01
Effect of OMEGA 3 Fatty Acids on Lactation Period
Celal Bayar University
Completed
NCT02538484 2023-07-17
Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects
The University of Texas Health Science Center at San Antonio
Phase EARLY_PHASE1 Completed
NCT01478477 2023-02-27
Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT03516253 2022-11-03
Fish Oil and EPO in Breast Cancer
University of Belgrade
Phase NA Unknown
NCT01821833 2022-10-05
Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel
New Mexico Cancer Research Alliance
Phase NA Completed
NCT01869764 2019-10-30
Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer
Wake Forest University Health Sciences
Phase 2 Completed
NCT02150525 2018-08-09
Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
NCT01548534 2015-07-29
DHALYA
University Hospital, Tours
Phase 3 Terminated
NCT01049295 2011-11-01
Omega-3 Fatty Acids and Chemotherapy-induced Neuropathy and Inflammation in Breast Cancer
Tehran University of Medical Sciences
Phase 4 Unknown